ABBVIE INC (ABBV) 145.14 +0.12 (+0.08%)
145.14 +0.12 (+0.08%)
US00287Y1091 - Common Stock - After market: 144.87 -0.27 (-0.19%)
Buy % Consensus
Analysts have set a mean price target of 165.75. This target is 14.2% above the current price.
ABBV was analyzed by 33 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about ABBV.
In the previous month the buy percentage consensus was at a similar level.
ABBV was analyzed by 33 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-02-06 | BMO Capital | Maintains | Outperform |
| 2023-01-17 | Piper Sandler | Maintains | Overweight |
| 2022-12-06 | Morgan Stanley | Maintains | Overweight |
| 2022-11-18 | Credit Suisse | Initiate | Outperform |
| 2022-11-08 | Societe Generale | Downgrade | Buy -> Hold |
| 2022-10-31 | Atlantic Equities | Maintains | Neutral |
| 2022-10-31 | BMO Capital | Maintains | Outperform |
| 2022-10-31 | Barclays | Maintains | Equal-Weight |
| 2022-10-31 | Morgan Stanley | Maintains | Overweight |
| 2022-10-11 | Morgan Stanley | Maintains | Overweight |
| 2022-09-30 | SVB Leerink | Maintains | Underperform |
| 2022-08-24 | Argus Research | Maintains | Buy |
| 2022-08-01 | Atlantic Equities | Maintains | Neutral |
| 2022-08-01 | UBS | Maintains | Neutral |
| 2022-08-01 | Barclays | Maintains | Equal-Weight |
| 2022-08-01 | Morgan Stanley | Maintains | Overweight |
| 2022-07-08 | Morgan Stanley | Maintains | Overweight |
| 2022-05-23 | SVB Leerink | Initiate | Underperform |
| 2022-05-02 | Wells Fargo | Maintains | Overweight |
| 2022-05-02 | Morgan Stanley | Maintains | Overweight |
| 2022-04-25 | BMO Capital | Maintains | Outperform |
| 2022-04-12 | Barclays | Maintains | Equal-Weight |
| 2022-04-12 | Goldman Sachs | Maintains | Neutral |
| 2022-02-28 | UBS | Downgrade | Buy -> Neutral |
| 2022-02-04 | Mizuho | Maintains | Buy |
| 2022-02-03 | Barclays | Maintains | Equal-Weight |
| 2022-01-24 | Morgan Stanley | Maintains | Overweight |
| 2022-01-20 | Barclays | Maintains | Equal-Weight |
| 2022-01-12 | BMO Capital | Maintains | Outperform |
| 2022-01-05 | Mizuho | Maintains | Buy |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA